Stay updated on SAGE-217 Safety in MDD Insomnia Clinical Trial
Sign up to get notified when there's something new on the SAGE-217 Safety in MDD Insomnia Clinical Trial page.

Latest updates to the SAGE-217 Safety in MDD Insomnia Clinical Trial page
- Check7 days agoChange DetectedA sitewide NIH notice appears above the page, announcing a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision label changes from v3.7.1 to v3.7.2. The page still displays a 403 error instead of the study record.SummaryDifference0.2%

- Check21 days agoChange DetectedThe revision identifier in the footer changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check41 days agoChange DetectedThe study page now displays a 403 Forbidden error instead of the study record details, blocking access to core information and related documents about the trial.SummaryDifference19%

- Check62 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6, indicating a minor version update to the page's metadata. The core study details remain unchanged.SummaryDifference0.0%

- Check83 days agoChange DetectedThe study page now displays a 500 error page ('An error occurred'), replacing the previously visible study record content and documents with an error screen.SummaryDifference18%

Stay in the know with updates to SAGE-217 Safety in MDD Insomnia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SAGE-217 Safety in MDD Insomnia Clinical Trial page.